T CELL RECOGNITION--REPERTOIRE IN AUTOIMMUNE THYROIDITIS

T 细胞识别——自身免疫性甲状腺炎的全部内容

基本信息

  • 批准号:
    2468037
  • 负责人:
  • 金额:
    $ 21.23万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1992
  • 资助国家:
    美国
  • 起止时间:
    1992-09-30 至 2001-12-31
  • 项目状态:
    已结题

项目摘要

The overall goal is to use murine experimental autoimmune thyroiditis (eat) as a model to probe the recognitory and pathogenic mechanisms leading to thyroid damage in Hashimoto's thyroititis (HT), the hypothyroid syndrome. A major thrust in this renewal application is the emphasis on the use of HLA class II transgenic mice and human thyroid antigens because of new findings culminated with the last 2 years. The new findings include: 1) HLA-DR3 transgene confers susceptibility to EAT-resistant, as well as class II-deficient mice, permitting EAT induction by either thyroglobulin (HTg) or mouse (M) Tg. 2) Similar to H2A polymorphism determining EAT susceptibility, HLA-DRB1 polymorphism is a determinant, since HLA-DR2 transgenic mice are resistant to MTg-induced EAT. 3) Preliminary data show that HLA-DQ polymorphism can also be demonstrated, with distinct responses to HTg or MTg, implicating HTg-unique, as well as MTg-unique, epitopes associated with each species. 4) The identification of certain conserved, thyroiditogenic thyroxine (T4)-containing peptides, which are not dependent on the variable iodine residues on Tg for immunogenicity, can now be studied in conjunction with unique epitopes. We propose to: 1. Determine the role of HLA class II genes in autoimmune thyroiditis by examining HLA-DRB1 and HLA-DQ polymorphism--potential for HLA association with HT. 2. Determine the mutual influence of HLA-DR and HLA-DQ genes in double transgenic mice on EAT susceptibility and resistance--with emphasis on gene complementation and down-regulation (protection). 3. Identify thyroiditogenic epitopes unique to MTg and HTg--examining T cell repertoire and function. 4. Determine if HLA association with Tg correlates with other major thyroid antigens--using recombinant thyroperoxidase (rTPO) and thyroid- stimulating hormone receptor (rTSHR).
总体目标是使用小鼠实验自身免疫性甲状腺炎

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

YI-CHI M. KONG其他文献

YI-CHI M. KONG的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('YI-CHI M. KONG', 18)}}的其他基金

TCELL RECOGNITION & REPERTOIRE IN AUTOIMMUNE THYROIDITIS
T细胞识别
  • 批准号:
    3247497
  • 财政年份:
    1992
  • 资助金额:
    $ 21.23万
  • 项目类别:
T Cell Recognition & Repertoire in Autoimmune Thyroditis
T细胞识别
  • 批准号:
    6543870
  • 财政年份:
    1992
  • 资助金额:
    $ 21.23万
  • 项目类别:
T Cell Recognition & Repertoire in Autoimmune Thyroditis
T细胞识别
  • 批准号:
    6757997
  • 财政年份:
    1992
  • 资助金额:
    $ 21.23万
  • 项目类别:
T CELL RECOGNITION & REPERTOIRE--AUTOIMMUNE THYROIDITIS
T细胞识别
  • 批准号:
    2145192
  • 财政年份:
    1992
  • 资助金额:
    $ 21.23万
  • 项目类别:
T Cell Recognition & Repertoire in Autoimmune Thyroditis
T细胞识别
  • 批准号:
    6640226
  • 财政年份:
    1992
  • 资助金额:
    $ 21.23万
  • 项目类别:
T CELL RECOGNITION & REPERTOIRE--AUTOIMMUNE THYROIDITIS
T细胞识别
  • 批准号:
    2145191
  • 财政年份:
    1992
  • 资助金额:
    $ 21.23万
  • 项目类别:
T CELL RECOGNITION & REPERTOIRE--AUTOIMMUNE THYROIDITIS
T细胞识别
  • 批准号:
    2016612
  • 财政年份:
    1992
  • 资助金额:
    $ 21.23万
  • 项目类别:
T CELL RECOGNITION--REPERTOIRE IN AUTOIMMUNE THYROIDITIS
T 细胞识别——自身免疫性甲状腺炎的全部内容
  • 批准号:
    2856762
  • 财政年份:
    1992
  • 资助金额:
    $ 21.23万
  • 项目类别:
T Cell Recognition & Repertoire in Autoimmune Thyroditis
T细胞识别
  • 批准号:
    6901008
  • 财政年份:
    1992
  • 资助金额:
    $ 21.23万
  • 项目类别:
T CELL RECOGNITION--REPERTOIRE IN AUTOIMMUNE THYROIDITIS
T 细胞识别——自身免疫性甲状腺炎的全部内容
  • 批准号:
    6138006
  • 财政年份:
    1992
  • 资助金额:
    $ 21.23万
  • 项目类别:

相似海外基金

Machine Learning of Disease Biomarkers from B and T cell Receptor Repertoires
来自 B 和 T 细胞受体库的疾病生物标志物的机器学习
  • 批准号:
    23K28188
  • 财政年份:
    2024
  • 资助金额:
    $ 21.23万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
The molecular basis of T cell receptor cross-reactivity between MHC and MR1
MHC 和 MR1 之间 T 细胞受体交叉反应的分子基础
  • 批准号:
    DP240102905
  • 财政年份:
    2024
  • 资助金额:
    $ 21.23万
  • 项目类别:
    Discovery Projects
CAREER: Understanding the Impact of Dephosphorylation Kinetics and Adapter Specificity on Synthetic T Cell Receptor Signaling and Function
职业:了解去磷酸化动力学和接头特异性对合成 T 细胞受体信号传导和功能的影响
  • 批准号:
    2339172
  • 财政年份:
    2024
  • 资助金额:
    $ 21.23万
  • 项目类别:
    Continuing Grant
Special Public T Cell Receptor Sequences that Predict Outcomes for Cancer Patients
预测癌症患者预后的特殊公共 T 细胞受体序列
  • 批准号:
    10577518
  • 财政年份:
    2023
  • 资助金额:
    $ 21.23万
  • 项目类别:
Machine Learning of Disease Biomarkers from B and T cell Receptor Repertoires
来自 B 和 T 细胞受体库的疾病生物标志物的机器学习
  • 批准号:
    23H03498
  • 财政年份:
    2023
  • 资助金额:
    $ 21.23万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Impact of T cell receptor signaling on memory CD8+ T cell stemness
T 细胞受体信号传导对记忆 CD8 T 细胞干性的影响
  • 批准号:
    10676407
  • 财政年份:
    2023
  • 资助金额:
    $ 21.23万
  • 项目类别:
T cell receptor cross-reactivity and structural basis of virus immune escape
T细胞受体交叉反应性和病毒免疫逃逸的结构基础
  • 批准号:
    22KK0277
  • 财政年份:
    2023
  • 资助金额:
    $ 21.23万
  • 项目类别:
    Fund for the Promotion of Joint International Research (Fostering Joint International Research (A))
T-cell receptor mimic affinity reagent generation using an in vivo novel immunogen strategy
使用体内新型免疫原策略生成 T 细胞受体模拟亲和试剂
  • 批准号:
    10599584
  • 财政年份:
    2023
  • 资助金额:
    $ 21.23万
  • 项目类别:
Mechanical regulation of T cell receptor and co-receptor responses in cancer immunotherapy
癌症免疫治疗中 T 细胞受体和辅助受体反应的机械调节
  • 批准号:
    10530023
  • 财政年份:
    2022
  • 资助金额:
    $ 21.23万
  • 项目类别:
Inhibition of T-cell Receptor Signaling for Treatment of Adult T-cell Leukemia Lymphoma
抑制 T 细胞受体信号转导治疗成人 T 细胞白血病淋巴瘤
  • 批准号:
    10684172
  • 财政年份:
    2022
  • 资助金额:
    $ 21.23万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了